CIK 0001690585 · Non-accelerated filer<br>Smaller reporting company
Dianthus Therapeutics, Inc. /DE/
Sign in to watch- Ticker
- DNTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 929-999-4055
- Business address
- 7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
- Former names
- Magenta Therapeutics, Inc.
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Results of operations · Regulation FD disclosure
- 4 Open-market sale See Remarks sold 11,200 shares at $15.25 ($170,800)
- 4 Open-market sale Chief Medical Officer sold 11,294 shares at $15.04 ($169,817)
- 4 Open-market sale See Remarks sold 2,800 shares at $15.10 ($42,280)
- 4/A Open-market sale See Remarks sold 12,083 shares at an average $16.01 ($193,473)
- 4 Open-market sale Chief Business Officer sold 4,463 shares at $16.01 ($71,453)
- 4 Open-market sale See Remarks sold 7,902 shares at $16.00 ($126,432)
- 4 Open-market sale See Remarks sold 4,181 shares at $16.03 ($67,021)
- 4 Open-market sale Chief Business Officer sold 9,867 shares at $16.03 ($158,168)
- 4 Open-market sale See Remarks sold 2,897 shares at $15.10 ($43,755)
- 4 Open-market sale See Remarks sold 76,711 shares at $15.16 ($1,162,617)
Page 26 of 33 · 659 filings